InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,460.48
(
-0.41%
)
US TECH 100
19,181.60
(
-0.43%
)
Dow Jones
39,118.86
(
-0.12%
)
Brent Oil
84.85
(
0.00%
)
Bitcoin
61,479.55
(
0.97%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Bxofscidad

Send PM Follow Ignore
Followers 0
Posts 232
Boards Moderated 0
Alias Born 06/13/2010

Bxofscidad

Re: biotech_researcher post# 26424

Thursday, 02/14/2013 10:53:33 AM

Thursday, February 14, 2013 10:53:33 AM

Post# of 80490
One clue is how he explained the EGFR patients that were in the trial earlier and their stage of the disease and the meds they took. There are other clues, especially how he talks about the EGFR arm of the Phase 2 cohort and also his reluctance to respond to the dosage they are up to. Learning Harvey- speak- has taken me many years. Last time I used it was to predict that PONA would be approved by the FDA by about mid December and not in 1st quarter 2013.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up